Capacity Worries Fade for Biomanufacturing

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-07-02-2003
Volume 27
Issue 7

The DSM investment puts biomanufacturing capacity in the spotlight. Contract biomanufacturers are adding new capacity and sponsors are marketing their excess capacity.

External Link - article-62505.pdf

Articles in this issue
July 2003
Gastrorentention: A Means to Address Regional Variability in Intestinal Drug Absorption
The Push for Generics Challenges Manufacturers
Emerging Research Opportunities in Oral Inhalation Technology
Understanding and Implementing a Risk-Based Approach to 21 CFR Part 11 Compliance
Preventing Metal Contamination
Capacity Worries Fade for Biomanufacturing
Recent Videos
CPHI Milan 2024: Highlighting the Benefits of Integrated Services
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Related Content
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Three New European Facilities Established by BioPharmaSpec for R&D

Feliza Mirasol
November 21st 2024
Article

Located in German, Italy, and Lithuania, the new European facilities will specialize in drug discovery and R&D services.

Drug Solutions Podcast: Unlocking the Latest Manufacturing Trends

Drug Solutions Podcast: Unlocking the Latest Manufacturing Trends

Felicity Thomas
July 11th 2023
Podcast

In this episode, Sergey Vlasenko from Agilent chats about bio/pharmaceutical manufacturing trends, with a particular focus on oligonucleotides.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Ascend Advanced Therapies Expands US Footprint in New Partnership

Susan Haigney
November 12th 2024
Article

Ascend is partnering with EW Healthcare Partners to expand capabilities in the United States.

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Felicity Thomas
May 2nd 2023
Podcast

In this episode, Hanns-Christian Mahler and Andrea Allmendinger from ten23 health will discuss some key aspects of biologic drug development and manufacturing.

Question mark background | Image Credit: © Leigh-Prather - © Leigh Prather - stock.adobe.com

The Importance of Appropriate Supplier Oversight

Siegfried Schmitt
November 2nd 2024
Article

The product license holder must have a supplier oversight system in place, says Siegfried Schmitt, PhD, vice president, Technical, Parexel.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Abzena Expands Microbiology Laboratory Space

Susan Haigney
October 30th 2024
Article

The company will be expanding its quality control testing capabilities at its San Diego, Calif. biologics development and manufacturing site.